Try our mobile app
Screener
Company
Price and
change
Revenue Growth
last / hist
EV /
LTM
EBITDA
(p75)
EV/
Sales
EBITDA LTM
/ Revenue
FCF LTM
/ Revenue
Next GAAP report
Year div-d yield
FCF Yield LTM
0.0%  /
0.0%
>200x
>200x
12.2x
0.0%
0.0%
..
0.0%
45.0% 
34.6%  /
27.7%
2.9x
3.8x
0.9x
31.5%
6.9%
..
5.4%
6.8% 
-3.8%  /
24.5%
21.6x
23.5x
19.4x
89.6%
35.7%
..
1.1%
1.8% 
-85.7%  /
95.0%
>200x
>200x
16.6x
-154.5%
415.2%
..
0.0%
24.7% 
-8.2%  /
14.6%
30.8x
25.1x
26x
84.3%
28.3%
..
0.9%
1.1% 
-3.4%  /
25.9%
17.4x
16.9x
2.1x
12.0%
-3.9%
..
2.0%
-2.2% 
0.0%  /
0.0%
19.2x
15x
19.2x
0.0%
0.0%
..
0.0%
-5.0% 
-56.5%  /
12.9%
17.4x
13.4x
13.1x
75.7%
46.8%
2025-02-12
1.1%
3.5% 
63.7%  /
32.5%
20.6x
15.7x
8.8x
42.5%
25.0%
2025-02-13
1.7%
2.9% 
-1.4%  /
7.4%
20.2x
20.9x
5.3x
26.0%
-13.9%
2025-02-13
0.7%
-3.0% 
-81.0%  /
-6.3%
>200x
15.3x
3x
-54.4%
11.5%
2025-02-18
0.8%
5.3% 
12.9%  /
20.4%
16.1x
14.7x
12.1x
75.6%
-66.4%
2025-02-18
1.0%
-5.4% 
37.0%  /
10.4%
22.8x
18.5x
9.5x
41.7%
1.1%
2025-02-19
0.4%
0.1% 
-12.0%  /
7.4%
>200x
11.3x
3.1x
-13.2%
-24.4%
2025-02-19
0.0%
-10.3% 
-16.1%  /
2.3%
7.3x
5.6x
4x
54.4%
-38.5%
2025-02-19
0.0%
-12.5% 
2.2%  /
-12.0%
35.3x
31.4x
20.7x
58.5%
171.3%
2025-02-19
0.9%
8.1% 
84.7%  /
15.4%
32.6x
28.1x
2.5x
7.7%
-17.2%
2025-02-20
2.1%
-7.9% 
-22.6%  /
0.0%
0.1x
1.5x
0.1x
63.8%
-4.7%
2025-02-26
0.0%
-19.4% 
Trending screeners:
@electric-vehicles
@saas
@cannabis-players
@china
Latin America
India
Dividends
@REITs
@adtech
@airlines
@artificial-intelligence
@auto-parts
@cloud-computing
@crypto
@cybersecurity
@e-commerce
@edtech
@finance-and-technology
@gaming
@internet-of-things
@oil-refining
@real-estate-tech
@renewable-energy
@vaccine-makers

Reviews

2025-02-15
#reports #TWLO

[Twilio](https://eninvs.com/all.php?name=TWLO) (Communication services provider) reported for 2024 q4
(2025-02-13, After Market Close):

- Revenue +11.1% YoY (vs +9.7% in previous quarter and historical rate +17.3%)
- EBITDA margin 4.9% increased compared to -28.0% same period last year
- Net Debt increased by $301 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0.9 bln (negative), 4.0% of market cap
- EV/Sales multiple is 4.9x

At the opening of the session the share price went down -10.5% vs S&P500 +0.1%
2025-02-15
#reports #TROW

[T Rowe Price](https://eninvs.com/all.php?name=TROW) (Financial services provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180172)
(2025-02-05, Before Market Open):

- Revenue +223.3% YoY (vs +6.9% in previous quarter and historical rate +14.1%)
- Net Income +250.6% YoY (vs +45.8% in previous quarter and historical rate +16.6%)
- Net Income margin 28.2% increased compared to 26.0% same period last year
- P/E multiple is 7.5x compared to historical level (75th percentile) of 14.6x
- P/S multiple is 2.3x
- Price to book: 2.3x

At the opening of the session the share price went down -2.5% vs S&P500 -0.2%
2025-02-15
#reports #RARE

[Ultragenyx Pharmaceutical](https://eninvs.com/all.php?name=RARE) (Medicines developer) reported for 2024 q4
(2025-02-13, After Market Close):

- Revenue +29.9% YoY (vs +41.8% in previous quarter and historical rate +17.7%)
- EBITDA margin -81.2% increased compared to -105.5% same period last year
- Net Debt increased by $80 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0 bln (positive), 1.6% of market cap
- EV/Sales multiple is 4x

At the opening of the session the share price went up +2.3% vs S&P500 +0.1%
2025-02-15
#reports #NUS

[Nu Skin Enterprises](https://eninvs.com/all.php?name=NUS) (Personal care products manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180161)
(2025-02-13, After Market Close):

- Revenue +295.3% YoY (vs -13.8% in previous quarter and historical rate +3.9%)
- EBITDA -128.6% YoY (vs +321.4% in previous quarter and historical rate -36.8%)
- EBITDA margin -0.3% decreased compared to 4.3% same period last year
- Net Debt decreased by $10 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0 bln (positive), 11.2% of market cap
- EV/Sales multiple is 0.2x

At the opening of the session the share price went up +38.3% vs S&P500 +0.1%
2025-02-15
#reports #NTGR

[NETGEAR](https://eninvs.com/all.php?name=NTGR) (IT services and products provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180173)
(2025-02-05, After Market Close):

- Revenue -3.7% YoY (vs -7.6% in previous quarter and historical rate -16.2%)
- EBITDA margin -7.1% decreased compared to -0.5% same period last year
- Net Debt decreased by $15 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 16.0% of market cap
- EV/EBITDA multiple is 21.4x compared to historical level (75th percentile) of 13.1x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -7.6% vs S&P500 +0.3%
2025-02-15
#reports #MITQ

[Moving iMage Technologies, Inc.](https://eninvs.com/all.php?name=MITQ) (Communication Equipment) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180296)
(2023-02-14, Before Market Open):

- Revenue 0% YoY (vs -28.6% in previous quarter and historical rate +40.1%)
- EV/Sales multiple is 0.2x

At the opening of the session the share price went up +6.3%
2025-02-15
#reports #IRMD

[IRadimed Corporation](https://eninvs.com/all.php?name=IRMD) (Medical Devices) reported for 2024 q4
(2025-02-13, Before Market Open):

- Revenue +11.8% YoY (vs +5.9% in previous quarter and historical rate +20.7%)
- EBITDA +20% YoY (vs 0.0% in previous quarter and historical rate +34.6%)
- EBITDA margin 31.6% increased compared to 29.4% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 28.2x compared to historical level (75th percentile) of 32.5x
- EV/Sales multiple is 8.9x

At the opening of the session the share price went down -4.2% vs S&P500 +0.2%
2025-02-15
#reports #EMKR

[EMCORE Corporation](https://eninvs.com/all.php?name=EMKR) (Semiconductors) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180235)
(2024-05-02, After Market Close):

- Revenue -20.8% YoY (vs -18.5% in previous quarter and historical rate -8.3%)
- EBITDA margin -15.8% increased compared to -16.7% same period last year
- Net Debt increased by $7 mln over the past reporting period (25.5% of market cap)
- FCF (LTM) -$0 bln (negative), 14.6% of market cap
- EV/Sales multiple is 0.6x

At the opening of the session the share price went up +1.6% vs S&P500 +1.2%
2025-02-15
#reports #DXCM

[DexCom](https://eninvs.com/all.php?name=DXCM) ( Medical equipment developer ) reported for 2024 q4
(2025-02-13, After Market Close):

- Revenue +7.7% YoY (vs +1.9% in previous quarter and historical rate +18.5%)
- EBITDA -12.8% YoY (vs -22.9% in previous quarter and historical rate +39.9%)
- EBITDA margin 19.6% decreased compared to 24.2% same period last year
- Net Debt decreased by $92 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0.2 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 47.1x compared to historical level (75th percentile) of 95.8x
- EV/Sales multiple is 8.7x

At the opening of the session the share price went up +2.3% vs S&P500 +0.1%
2025-02-15
#reports #BRKR

[Bruker](https://eninvs.com/all.php?name=BRKR) ( Medical equipment manufacturer ) reported for 2024 q4
(2025-02-13, Before Market Open):

- Revenue +14.8% YoY (vs +16.3% in previous quarter and historical rate +11.7%)
- EBITDA -11.3% YoY (vs -21.2% in previous quarter and historical rate -2.9%)
- EBITDA margin 12.8% decreased compared to 16.5% same period last year
- Net Debt decreased by $238 mln over the past reporting period (3.2% of market cap)
- FCF (LTM) -$1 bln (negative), 13.5% of market cap
- EV/EBITDA multiple is 21.5x compared to historical level (75th percentile) of 23.4x
- EV/Sales multiple is 2.8x

At the opening of the session the share price went up +2.8% vs S&P500 +0.2%
2025-02-15
#reports #REG
@ REITs

[Regency Centers](https://eninvs.com/all.php?name=REG) (Real estate investment fund) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180246)
(2025-02-06, After Market Close):

- Revenue +3.6% YoY (vs +8.8% in previous quarter and historical rate +7.8%)
- EBITDA +51.4% YoY (vs +21.3% in previous quarter and historical rate +51.4%)
- EBITDA margin 87.7% increased compared to 60.0% same period last year
- EV/EBITDA multiple is 13.5x compared to historical level (75th percentile) of 28.6x
- EV/Sales multiple is 8.4x

At the opening of the session the share price went up +0.1% vs S&P500 +0.2%
2025-02-15
#reports #PLD
@ REITs

[Prologis](https://eninvs.com/all.php?name=PLD) (Real estate investment trust) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180167)
(2025-01-21, Before Market Open):

- Revenue +16.5% YoY (vs +6.3% in previous quarter and historical rate +22.8%)
- EBITDA +22.5% YoY (vs +9.8% in previous quarter and historical rate +35.6%)
- EBITDA margin 71.4% increased compared to 67.9% same period last year
- EV/EBITDA multiple is 19.7x compared to historical level (75th percentile) of 26.7x
- EV/Sales multiple is 13.7x

At the opening of the session the share price went up +0.7% vs S&P500 +0.3%
2025-02-15
#reports #ZBRA

[Zebra Technologies](https://eninvs.com/all.php?name=ZBRA) (Mobile computer manufacturer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180153)
(2025-02-13, Before Market Open):

- Revenue +32.2% YoY (vs +31.3% in previous quarter and historical rate -2.0%)
- EBITDA -40.8% YoY (vs +634.4% in previous quarter and historical rate +9.0%)
- EBITDA margin 16.9% decreased compared to 37.7% same period last year
- EV/EBITDA multiple is 21.7x compared to historical level (75th percentile) of 23x
- EV/Sales multiple is 3.8x

At the opening of the session the share price went down -6.6% vs S&P500 +0.2%
2025-02-15
#reports #YELP

[Yelp](https://eninvs.com/all.php?name=YELP) (Crowdsourcing platform) reported for 2024 q4
(2025-02-13, After Market Close):

- Revenue +5.8% YoY (vs +4.3% in previous quarter and historical rate +11.2%)
- EBITDA +140% YoY (vs +26.9% in previous quarter and historical rate +57.1%)
- EBITDA margin 23.2% increased compared to 10.2% same period last year
- Net Debt increased by $68 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) -$0 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 10.2x compared to historical level (75th percentile) of 22.3x
- EV/Sales multiple is 1.6x

At the opening of the session the share price went down -1.3% vs S&P500 +0.1%
2025-02-15
#reports #WYNN

[Wynn Resorts](https://eninvs.com/all.php?name=WYNN) (Hotel and casino chain owner) reported for 2024 q4
(2025-02-13, After Market Close):

- Revenue -0.1% YoY (vs +1.3% in previous quarter and historical rate +28.7%)
- EBITDA -3% YoY (vs +23.4% in previous quarter and historical rate +84.2%)
- EBITDA margin 28.2% decreased compared to 29.0% same period last year
- EV/EBITDA multiple is 5.4x compared to historical level (75th percentile) of 34.3x
- EV/Sales multiple is 1.4x

At the opening of the session the share price went up +5.2% vs S&P500 +0.1%
2025-02-15
#reports #WST

[West Pharmaceutical Services](https://eninvs.com/all.php?name=WST) (Drug packaging and delivery systems developer) reported for 2024 q4
(2025-02-13, Before Market Open):

- Revenue +2.3% YoY (vs 0.0% in previous quarter and historical rate +0.8%)
- EBITDA +29.4% YoY (vs -62.0% in previous quarter and historical rate +33.9%)
- EBITDA margin 81.7% increased compared to 64.6% same period last year
- Net Debt increased by $186 mln over the past reporting period (1.2% of market cap)
- EV/EBITDA multiple is 8x compared to historical level (75th percentile) of 18.2x
- EV/Sales multiple is 5.5x

At the opening of the session the share price went down -24.3% vs S&P500 +0.2%
2025-02-15
#reports #WEN

[Wendys](https://eninvs.com/all.php?name=WEN) (Restaurants) reported for 2024 q4
(2025-02-13, Before Market Open):

- Revenue +6.1% YoY (vs +2.9% in previous quarter and historical rate +18.3%)
- EBITDA +11.1% YoY (vs -5.8% in previous quarter and historical rate -11.1%)
- EBITDA margin 17.4% increased compared to 16.6% same period last year
- Net Debt increased by $38 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$0 bln (negative), 1.5% of market cap
- EV/EBITDA multiple is 17.4x compared to historical level (75th percentile) of 18.1x
- EV/Sales multiple is 3x

At the opening of the session the share price went down -1.5% vs S&P500 +0.2%
2025-02-15
#reports #VNDA

[Vanda Pharmaceuticals](https://eninvs.com/all.php?name=VNDA) (Small molecule drugs developer) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180150)
(2025-02-13, After Market Close):

- Revenue +17.8% YoY (vs +23.1% in previous quarter and historical rate -7.7%)
- EBITDA margin -18.9% decreased compared to -15.6% same period last year
- Net Debt increased by $4 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0 bln (negative), 5.4% of market cap
- EV/EBITDA multiple is 2.8x compared to historical level (75th percentile) of 9.7x
- EV/Sales multiple is -0.6x

At the opening of the session the share price went down -2.6% vs S&P500 +0.1%
2025-02-15
#reports #UDMY

[Udemy, Inc.](https://eninvs.com/all.php?name=UDMY) (Education and Training Services) reported for 2024 q4
(2025-02-13, After Market Close):

- Revenue +5.3% YoY (vs +5.4% in previous quarter and historical rate +13.7%)
- EBITDA margin 5.0% increased compared to -2.6% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 5.0% of market cap
- EV/Sales multiple is 1.4x

At the opening of the session the share price went up +7.0% vs S&P500 +0.1%
2025-02-15
#reports #TRU

[TransUnion](https://eninvs.com/all.php?name=TRU) (Banking service provider) reported for [2024 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=180149)
(2025-02-13, Before Market Open):

- Revenue +8.7% YoY (vs +12.0% in previous quarter and historical rate +10.8%)
- EBITDA +11.6% YoY (vs +28900.0% in previous quarter and historical rate -1.2%)
- EBITDA margin 29.7% increased compared to 28.9% same period last year
- Net Debt decreased by $93 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.4 bln (positive), 2.0% of market cap
- EV/EBITDA multiple is 19.7x compared to historical level (75th percentile) of 28.7x
- EV/Sales multiple is 5.7x

At the opening of the session the share price went up +1.7% vs S&P500 +0.2%
2025-02-15
#reports #TAP

[Molson Coors Beverage](https://eninvs.com/all.php?name=TAP) (Beer maker) reported for [2024 q4](https://eninvs.com/press_release.php?ticker=TAP&q=2024 q4&id=828106)
(2025-02-13, Before Market Open):

- Revenue -2.7% YoY (vs -7.8% in previous quarter and historical rate +11.0%)
- EBITDA +70.2% YoY (vs -17.6% in previous quarter and historical rate +21.3%)
- EBITDA margin 19.6% increased compared to 11.2% same period last year
- Net Debt increased by $96 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 16.9x
- EV/Sales multiple is 1.4x

At the opening of the session the share price went up +7.1% vs S&P500 +0.2%